# Bristol-Myers Squibb Company (BMY): MoatMap facts

As of 14 Oct 2026. Research data, not investment advice.

As of 14 Oct 2026, MoatMap's StockRank for Bristol-Myers Squibb Company (BMY) is 98/100, ranked against 24,000+ stocks in 35 markets (Quality 74, Value 69, Momentum 71, each scored against its sector).

- StockRank: 98/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 74, Value 69, Momentum 71: each a 0-100 percentile within the stock's sector.
- Position: #419 overall, #53 in Healthcare.
- Listing: United States, NYQ; Healthcare / Drug Manufacturers - General.
- Last close: 57.58 USD on 12 Oct 2026.
- Insider filings, last 180 days: directors sold USD 437K.

Source: https://moatmap.ai/stock/BMY
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker